MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation ROE Ratio 2011-2026 | EW
Annual ROE Ratio Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.38 | 41.75 | 20.87 | 26.21 | 25.76 | 18.0 | 25.24 | 23.0 | 19.74 | 21.74 | 19.77 | 37.01 | 25.12 | 19.82 | 17.69 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 41.75 | 10.38 | 23.47 |
Quarterly ROE Ratio Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.5 | 70.59 | 72.31 | 41.73 | 47.45 | 21.22 | 21.1 | 16.1 | 21.63 | 21.43 | 23.5 | 18.75 | 24.89 | 25.5 | 28.2 | 22.93 | 29.7 | 30.67 | 18.47 | 18.0 | 17.99 | 17.5 | 26.01 | 25.24 | 18.71 | 19.28 | 22.44 | 23.0 | 22.68 | 21.24 | 18.53 | 19.74 | 25.89 | 25.53 | 24.07 | 21.74 | 21.31 | 20.63 | 20.3 | 19.77 | 19.13 | 18.73 | 39.19 | 37.01 | 36.89 | 37.55 | 18.63 | 25.19 | 26.54 | 26.25 | 24.79 | 19.87 | 18.42 | 17.59 | 17.35 | 17.73 | 3.86 | 4.34 | 4.78 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 72.31 | 3.86 | 24.77 |
ROE Ratio of other stocks in the Medical devices industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
669.04 | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-19.79 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-10.47 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-115.26 | - | 24.59 % | $ 44.8 M |  China |
 |
Xtant Medical Holdings
XTNT
|
-38.29 | $ 0.55 | -2.31 % | $ 73.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
-334.18 | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
192.9 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
9290.44 | - | -26.83 % | $ 2.62 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
7.25 | $ 88.57 | -0.65 % | $ 18 B | USA |
 |
Allied Healthcare Products
AHPI
|
-36.97 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-264.39 | - | -5.86 % | $ 30.6 M | USA |
 |
Alphatec Holdings
ATEC
|
-1153.69 | $ 10.93 | -5.12 % | $ 1.64 B | USA |
 |
Conformis
CFMS
|
-93.16 | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
-1.96 | $ 0.4 | 4.21 % | $ 41.1 M | USA |
 |
Insulet Corporation
PODD
|
16.31 | $ 208.22 | -4.53 % | $ 14.6 B | USA |
 |
Cardiovascular Systems
CSII
|
-14.8 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
-169.16 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-122.23 | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
295.39 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
-5.07 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-910.25 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
4.55 | $ 34.58 | -5.62 % | $ 1.07 B | USA |
 |
Soliton, Inc.
SOLY
|
-46.94 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-0.13 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-25.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
-590.91 | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
-11.88 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-1451.06 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
-107.92 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-186.54 | $ 0.59 | -1.18 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
-261.31 | $ 2.15 | -5.29 % | $ 3.36 M | USA |
 |
BIOLASE
BIOL
|
8353.04 | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
-4.66 | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-11.44 | $ 15.52 | -5.08 % | $ 364 M | USA |
 |
Invacare Corporation
IVC
|
-25.37 | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
-290.12 | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
-136.57 | $ 0.7 | 2.32 % | $ 29.3 M | USA |
 |
Penumbra
PEN
|
12.45 | $ 335.1 | -0.39 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
18.62 | $ 50.13 | -0.63 % | $ 1.47 B | USA |
 |
Pulmonx Corporation
LUNG
|
-99.79 | $ 1.17 | -5.65 % | $ 47.6 M | USA |
 |
Cutera
CUTR
|
33.31 | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
-156.15 | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
4.65 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
-49.11 | - | - | $ 217 M | USA |
 |
Surgalign Holdings
SRGA
|
212.23 | - | -32.98 % | $ 1.68 M | USA |
 |
STRATA Skin Sciences
SSKN
|
-25.42 | - | - | $ 6.6 M | USA |
 |
GBS
GBS
|
-352.75 | - | -0.57 % | $ 7.12 M | USA |
 |
AVITA Medical
RCEL
|
291.81 | $ 3.82 | -1.04 % | $ 106 M |  Australia |
 |
AxoGen
AXGN
|
-12.19 | $ 31.28 | -3.01 % | $ 1.44 B | USA |